Skip to main content

Table 1 Baseline characteristics of patients undergoing partial mastectomy

From: Protective effect of remifentanil on blood loss in endoscopic subcutaneous mastectomy: a retrospective study

 

Partial mastectomy

Quadrantectomy

Total

Remifentanil

Non-remifentanil

P value

Total

Remifentanil

Non-remifentanil

P value

n = 231

n = 98

n = 133

 

n = 212

n = 56

n = 156

 

Age, years

51 ± 12

51 ± 5

53 ± 7

0.43

52 ± 11

51 ± 11

52 ± 12

0.36

Body weight, kg

55 [50, 62]

55 [50, 60]

55 [50, 63]

0.51

55 [50, 62]

55 [50, 62]

56 [51, 61]

0.85

Height, cm

157 ± 6

157 ± 5

157 ± 7

0.85

156 ± 6

157 ± 7

156 ± 6

0.35

BMI, kg/m2

22.4 [20.3, 25.0]

22.4 [20.0, 25.4]

22.3 [20.4, 24.7]

0.72

22.4 [20.3, 25.0]

22.4 [20.3, 25.0]

22.7 [20.7, 25.3]

0.43

ASA-PS 1, n (%)

108/231 (47)

45/98 (46)

63/133 (47)

0.93

85/212 (40)

24/56 (43)

61/156 (39)

0.74

  1. BMI body mass index, ASA-PS American Society of Anesthesiologists physical status
  2. Continuous variables with normal distribution and with skewed distribution were expressed as mean ± SD and median [25%, 75%]. Categorical variable (ASA-PS) was expressed as number (%). Continuous variables were analyzed using Student’s t test or the Mann–Whitney U test along with the distribution of each variable as appropriate. Categorical variables were analyzed using Fisher exact test. Apart from ASA-PS 1, it was ASA-PS 2